期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
From a Deadly Disease to a Manageable Chronic Disease,HIV/AIDS Remains a Challenge for Mankind 被引量:1
1
作者 shimiao shao Yiming shao 《Infectious Microbes & Diseases》 CSCD 2023年第2期41-43,共3页
Acquired immune deficiency syndrome(AIDS)is caused by human immunodeficiency virus(HIV),which was found by French scientists 40 years ago,12 years after AIDS was firstly reported by US scientists.2 TheHIV/AIDS pandemi... Acquired immune deficiency syndrome(AIDS)is caused by human immunodeficiency virus(HIV),which was found by French scientists 40 years ago,12 years after AIDS was firstly reported by US scientists.2 TheHIV/AIDS pandemic has spread to every country of theworldwith over 84 million infections and more than 40 million deaths since the start of the epidemic.3 According to Joint United Nations Programme on HIV/AIDS(UNAIDS),there are 38.4 million people living with HIV/AIDS(PLWHA)in 2021.4 In order to realize the Ending AIDS Plan by 2030,the UNAIDS made the intermediate target of less than 500,000 new HIV infections and 500,000 AIDS-related deaths in 2020.5 In the 2021 United Nations(UN)75th General Assembly,the General Secretary reported that the 2020 target of Ending AIDS Plan was not reached,6 with 1.7 million HIV infections and 690,000 AIDS-related deaths in 2019.7 In order to bring the Ending AIDS Plan back on track,UNAIDS setup a higher goal of“95-95-95,”meaning the percentage for all PLWHA who know their HIV status. 展开更多
关键词 acquired immune deficiency syndrome human immunodeficiency virus combination antiretroviral therapy molecular transmission network
原文传递
Infectious Microbes&Diseases Contributing to COVID-19 Prevention and Control
2
作者 Qiong Zhang Yueyue He +2 位作者 Xiang Li shimiao shao Stijn van der Veen 《Infectious Microbes & Diseases》 CSCD 2023年第1期1-2,共2页
Since the start of the outbreak of coronavirus disease 2019(COVID-19)in January 2020,the pandemic has been raging on for 3 years,with a devastating impact on human health,resulting globally in 663,248,631 confirmed in... Since the start of the outbreak of coronavirus disease 2019(COVID-19)in January 2020,the pandemic has been raging on for 3 years,with a devastating impact on human health,resulting globally in 663,248,631 confirmed infections and 6,709,387 confirmed deaths as of January 19,2023.1 Facing this remarkably fast developing pandemic with limited knowledge on many aspects of the disease,including transmission,effective infection control,morbidity and treatment,researchers and practitioners worldwide have switched their focus to COVID-19–related research and practices.According to incomplete statistics,more than 330,000 COVID-19–related publications have been indexed in PubMed by January 19,2023,2 which carried out comprehensive and multifaceted studies on COVID-19.These research findings have played a key role in controlling the spread of COVID-19,treating severe and/or critical cases,and reducing the morbidity and mortality. 展开更多
关键词 FIR COV INCOMPLETE
原文传递
What Can We Do in the Game Between Bacterial Antibiotic Resistance and Antibiotic Application?
3
作者 Qiong Zhang Yueyue He +1 位作者 Xiang Li shimiao shao 《Infectious Microbes & Diseases》 2022年第4期137-138,共2页
It has been more than 80 years since penicillin was applied for the treatment of human bacterial infections.During this period,new antibiotics have been discovered and applied continuously.However,in order to copewith... It has been more than 80 years since penicillin was applied for the treatment of human bacterial infections.During this period,new antibiotics have been discovered and applied continuously.However,in order to copewith the threat of antibiotics,bacteria have also evolved by accumulating adaptive mutations or acquiring and spreading drug resistance genes.Today,the global high rate of drug resistance,1 multiple drug resistance2 and even the emergence of“super bugs”3 have posed new challenges to the treatment of bacterial infections. 展开更多
关键词 Antibiotic RESISTANCE TREATMENT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部